Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer Publication Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer CertaraDecember 18, 2016
Phoenix IVIVC Toolkit Brochure Phoenix IVIVC Toolkit Explore the comprehensive features of the IVIVC Toolkit.CertaraDecember 14, 2016
Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy Publication Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy CertaraDecember 5, 2016
The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves Publication The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves This study describes the pharmacokinetics of topical and intravenous (IV) flunixin meglumine in Holstein calves.…CertaraDecember 1, 2016
Limitations of MIC as Sole Metric of Pharmacodynamic Response Across the Range of Antimicrobial Susceptibilities within a Single Bacterial Species Publication Limitations of MIC as Sole Metric of Pharmacodynamic Response Across the Range of Antimicrobial Susceptibilities within a Single Bacterial Species The minimum inhibitory concentration (MIC) of an antimicrobial drug for a bacterial pathogen is used…CertaraDecember 1, 2016
Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage Publication Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage CertaraDecember 1, 2016
Pinnacle 21 Wins TOPRA Award for Regulatory Excellence in Innovation Announcement Pinnacle 21 Wins TOPRA Award for Regulatory Excellence in Innovation Certara’s Pinnacle 21 is honored to announce that Max Kanevsky, has been named to the…CertaraDecember 1, 2016
Quantifying Gut Wall Metabolism: Methodology Matters Publication Quantifying Gut Wall Metabolism: Methodology Matters CertaraDecember 1, 2016